OBJECTIVE: The goal of this study was to examine the effect of insulin resistance (IR) in subjects without diabetes on the relationship of a dyslipidemia with high triglycerides and low high-density lipoprotein cholesterol (HDL-C) to the development of coronary heart disease (CHD). METHODS AND RESULTS: Lower and higher fasting plasma HDL-C and triglyceride concentrations (defined at the study population median) and presence or absence of IR (defined by upper quartile Homeostatic Model Assessment values) were related to the development of myocardial infarction or CHD death in Framingham Heart Study participants without diabetes or a history of CHD (n=2910) attending the 1991 to 1995 examination. During follow-up (mean, 14 years), 128 participants experienced an incident CHD event. With Kaplan-Meier plots, the incidence of CHD was significantly greater with than without IR at either the lowest HDL-C or the highest triglycerides (P<0.001). In multivariable Cox models adjusted for major CHD risk factors, including waist circumference, only subgroups with IR had a significantly higher incidence of CHD. Compared with a reference group without IR and with higher-than-median HDL-C or lower-than-median triglycerides, the hazard ratio (HR) for incident events was significant with only IR and a lower HDL-C (HR 2.83, P<0.001) or higher triglycerides (HR 2.50, P<0.001). These findings were similar in men and women. CONCLUSIONS: In this community-based sample exclusive of diabetes, incident CHD risk associated with plasma HDL-C or triglycerides was significantly increased only in the presence of IR.
OBJECTIVE: The goal of this study was to examine the effect of insulin resistance (IR) in subjects without diabetes on the relationship of a dyslipidemia with high triglycerides and low high-density lipoprotein cholesterol (HDL-C) to the development of coronary heart disease (CHD). METHODS AND RESULTS: Lower and higher fasting plasma HDL-C and triglyceride concentrations (defined at the study population median) and presence or absence of IR (defined by upper quartile Homeostatic Model Assessment values) were related to the development of myocardial infarction or CHD death in Framingham Heart Study participants without diabetes or a history of CHD (n=2910) attending the 1991 to 1995 examination. During follow-up (mean, 14 years), 128 participants experienced an incident CHD event. With Kaplan-Meier plots, the incidence of CHD was significantly greater with than without IR at either the lowest HDL-C or the highest triglycerides (P<0.001). In multivariable Cox models adjusted for major CHD risk factors, including waist circumference, only subgroups with IR had a significantly higher incidence of CHD. Compared with a reference group without IR and with higher-than-median HDL-C or lower-than-median triglycerides, the hazard ratio (HR) for incident events was significant with only IR and a lower HDL-C (HR 2.83, P<0.001) or higher triglycerides (HR 2.50, P<0.001). These findings were similar in men and women. CONCLUSIONS: In this community-based sample exclusive of diabetes, incident CHD risk associated with plasma HDL-C or triglycerides was significantly increased only in the presence of IR.
Authors: Eyal Shahar; Lloyd E Chambless; Wayne D Rosamond; Lori L Boland; Christie M Ballantyne; Paul G McGovern; A Richey Sharrett Journal: Stroke Date: 2003-02-20 Impact factor: 7.914
Authors: M L Bots; P C Elwood; Y Nikitin; J T Salonen; A Freire de Concalves; D Inzitari; J Sivenius; V Benetou; J Tuomilehto; P J Koudstaal; D E Grobbee Journal: J Epidemiol Community Health Date: 2002-02 Impact factor: 3.710
Authors: I Lemieux; A Pascot; C Couillard; B Lamarche; A Tchernof; N Alméras; J Bergeron; D Gaudet; G Tremblay; D Prud'homme; A Nadeau; J P Després Journal: Circulation Date: 2000-07-11 Impact factor: 29.690
Authors: Sander J Robins; Hanna Bloomfield Rubins; Fred H Faas; Ernst J Schaefer; Marshall B Elam; James W Anderson; Dorothea Collins Journal: Diabetes Care Date: 2003-05 Impact factor: 19.112
Authors: William B Kannel; Ramachandran S Vasan; Michelle J Keyes; Lisa M Sullivan; Sander J Robins Journal: Am J Cardiol Date: 2008-02-15 Impact factor: 2.778
Authors: Peter Manu; Constantin Ionescu-Tirgoviste; James Tsang; Barbara A Napolitano; Martin L Lesser; Christoph U Correll Journal: Obes Res Clin Pract Date: 2012-01 Impact factor: 2.288
Authors: Anca D Petrescu; Huan Huang; Gregory G Martin; Avery L McIntosh; Stephen M Storey; Danilo Landrock; Ann B Kier; Friedhelm Schroeder Journal: Am J Physiol Gastrointest Liver Physiol Date: 2012-12-13 Impact factor: 4.052
Authors: Lorisa S Teixeira; Arleilson S Lima; Ana Paula A Boleti; Adley A N Lima; Said T Libório; Lucia de Paula; Maria Inês B Oliveira; Everton F Lima; Geison M Costa; Flávio H Reginatto; Emerson S Lima Journal: J Nat Med Date: 2014-04 Impact factor: 2.343
Authors: Tzu-Chieh Chen; Rebecca A Lee; Sam L Tsai; Deepthi Kanamaluru; Nora E Gray; Nicholas Yiv; Rachel T Cheang; Jenna H Tan; Justin Y Lee; Mark D Fitch; Marc K Hellerstein; Jen-Chywan Wang Journal: J Biol Chem Date: 2019-05-03 Impact factor: 5.157
Authors: Wassef Karrowni; Yan Li; Philip G Jones; Sharon Cresci; Mouin S Abdallah; David E Lanfear; Thomas M Maddox; Darren K McGuire; John A Spertus; Phillip A Horwitz Journal: Arterioscler Thromb Vasc Biol Date: 2013-07-18 Impact factor: 8.311
Authors: Mihoko Yoshino; Brandon D Kayser; Jun Yoshino; Richard I Stein; Dominic Reeds; J Christopher Eagon; Shaina R Eckhouse; Jeramie D Watrous; Mohit Jain; Rob Knight; Kenneth Schechtman; Bruce W Patterson; Samuel Klein Journal: N Engl J Med Date: 2020-08-20 Impact factor: 91.245